These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9669294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Graves' ophthalmopathy].
    Badelon I, Morax S.
    Rev Prat; 2005 Jan 31; 55(2):183-6. PubMed ID: 15826000
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L, Norberg R.
    Invest Ophthalmol Vis Sci; 1988 Feb 31; 29(2):175-84. PubMed ID: 2448263
    [Abstract] [Full Text] [Related]

  • 5. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A, Perrino S, Coronella C, Sansone D, Ruocco G, Tirelli G, Di Martino S, Conte M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2004 Jun 31; 60(6):694-8. PubMed ID: 15163332
    [Abstract] [Full Text] [Related]

  • 6. Correlation between NMR scans of extraocular muscles and clinical symptoms in Graves' ophthalmopathy.
    Troelstra A, Rijneveld WJ, Kooijman AC, Houtman WA.
    Doc Ophthalmol; 1988 Jun 31; 70(2-3):243-9. PubMed ID: 3234192
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathogenesis and treatment of the ophthalmopathy associated with Graves' disease.
    Velkeniers B, Salu P.
    Bull Soc Belge Ophtalmol; 1992 Jun 31; 245():9-14. PubMed ID: 1344754
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B, Musselman R, Adams CL, Tani J, Beard N, Wall JR.
    Thyroid; 2006 Oct 31; 16(10):967-74. PubMed ID: 17042681
    [Abstract] [Full Text] [Related]

  • 15. Radiotherapy for Graves' ophthalmopathy: results at one year.
    Gorman CA.
    Thyroid; 2002 Mar 31; 12(3):251-5. PubMed ID: 11952049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F, Zamboni G, Cerini R, Lauriola S, Dall'Agnola A, Tatò L.
    J Pediatr; 2004 Apr 31; 144(4):527-31. PubMed ID: 15069405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.